Research programme: serotonin 5HT1a and alpha 1a adrenergic receptor agonist - Cenomed
Alternative Names: CM-2,236Latest Information Update: 16 Jul 2016
At a glance
- Originator Cenomed BioSciences
- Class
- Mechanism of Action 5-HT1A serotonin receptor agonists; Alpha 1 adrenergic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Post-traumatic stress disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Post-traumatic-stress-disorder in USA